-
Something wrong with this record ?
Progress of local symptoms of superficial vein thrombosis vs. duplex findings
G. Górski, W. Noszczyk, W. Kostewicz, P. Szopiński, M. Kielar, J. Michalak, A. Marianowska, D. Wilkoswski,
Language English Country Switzerland
Document type Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- MeSH
- Adult MeSH
- Risk Assessment methods MeSH
- Middle Aged MeSH
- Humans MeSH
- Disease Progression MeSH
- Risk Factors MeSH
- Sex Distribution MeSH
- Aged MeSH
- Severity of Illness Index * MeSH
- Ultrasonography MeSH
- Venous Thrombosis classification diagnostic imaging epidemiology MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Clinical Trial MeSH
- Multicenter Study MeSH
- Research Support, Non-U.S. Gov't MeSH
- Randomized Controlled Trial MeSH
- Geographicals
- Czech Republic MeSH
- Poland epidemiology MeSH
BACKGROUND: Risk of subsequent deep vein thrombosis (DVT) following superficial vein thrombosis (SVT) is not fully appreciated. Mechanisms, time relations and risk factors for DVT arising upon earlier SVT remain unclear. The aim of this study was to analyze time relations between local symptoms of lower limb superficial vein thrombosis, duplex findings and onset of deep vein thrombosis during clinically evident course of SVT. PATIENTS AND METHODS: 46 patients with early (onset less than 72 hours prior to inclusion) clinical diagnosis of SVT, confirmed ultrasonographically were included in this prospective, multicenter study. Progress of pain, erythema and swelling in relation to subsequent ultrasound changes in size and localization of thrombus at 0, 7, 14 and 21 day of study has been recorded. RESULTS: Local symptoms subsided completely during 3 weeks. At that time thrombus disappeared completely only in 26% of cases, in remaining cases decreased in size from average 117.5 mm to 43.0 mm. Thrombus regression was similar to venous blood outflow direction--proximal to femoral area. Thrombus propagation was observed following regression of local symptoms of SVT. 4 cases of DVT (8.7%) were diagnosed at 2-11 days. CONCLUSIONS: Local, clinically detectable symptoms of SVT regress incomparably quicker than thrombus in affected veins. Risk of further thrombus propagation extends well beyond the period of intensive local symptoms of SVT. Regression of thrombus in femoral area requires significantly more time than in popliteal or calf segment. Thrombus propagation is directed with blood flow towards femoral segment.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20013845
- 003
- CZ-PrNML
- 005
- 20200923101030.0
- 007
- ta
- 008
- 200911s2004 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1024/0301-1526.33.4.219 $2 doi
- 035 __
- $a (PubMed)15623197
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Górski, G $u Department of General and Vascular Surgery, Medical Academy Warszawa, Poland. ggorski@amwaw.edu.pl
- 245 10
- $a Progress of local symptoms of superficial vein thrombosis vs. duplex findings / $c G. Górski, W. Noszczyk, W. Kostewicz, P. Szopiński, M. Kielar, J. Michalak, A. Marianowska, D. Wilkoswski,
- 520 9_
- $a BACKGROUND: Risk of subsequent deep vein thrombosis (DVT) following superficial vein thrombosis (SVT) is not fully appreciated. Mechanisms, time relations and risk factors for DVT arising upon earlier SVT remain unclear. The aim of this study was to analyze time relations between local symptoms of lower limb superficial vein thrombosis, duplex findings and onset of deep vein thrombosis during clinically evident course of SVT. PATIENTS AND METHODS: 46 patients with early (onset less than 72 hours prior to inclusion) clinical diagnosis of SVT, confirmed ultrasonographically were included in this prospective, multicenter study. Progress of pain, erythema and swelling in relation to subsequent ultrasound changes in size and localization of thrombus at 0, 7, 14 and 21 day of study has been recorded. RESULTS: Local symptoms subsided completely during 3 weeks. At that time thrombus disappeared completely only in 26% of cases, in remaining cases decreased in size from average 117.5 mm to 43.0 mm. Thrombus regression was similar to venous blood outflow direction--proximal to femoral area. Thrombus propagation was observed following regression of local symptoms of SVT. 4 cases of DVT (8.7%) were diagnosed at 2-11 days. CONCLUSIONS: Local, clinically detectable symptoms of SVT regress incomparably quicker than thrombus in affected veins. Risk of further thrombus propagation extends well beyond the period of intensive local symptoms of SVT. Regression of thrombus in femoral area requires significantly more time than in popliteal or calf segment. Thrombus propagation is directed with blood flow towards femoral segment.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a progrese nemoci $7 D018450
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a Polsko $x epidemiologie $7 D011044
- 650 _2
- $a hodnocení rizik $x metody $7 D018570
- 650 _2
- $a rizikové faktory $7 D012307
- 650 12
- $a stupeň závažnosti nemoci $7 D012720
- 650 _2
- $a rozložení podle pohlaví $7 D017678
- 650 _2
- $a ultrasonografie $7 D014463
- 650 _2
- $a žilní trombóza $x klasifikace $x diagnostické zobrazování $x epidemiologie $7 D020246
- 651 _2
- $a Česká republika $x epidemiologie $7 D018153
- 655 _2
- $a klinické zkoušky $7 D016430
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a multicentrická studie $7 D016448
- 655 _2
- $a randomizované kontrolované studie $7 D016449
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Noszczyk, W
- 700 1_
- $a Kostewicz, W
- 700 1_
- $a Szopiński, P
- 700 1_
- $a Kielar, M
- 700 1_
- $a Michalak, J
- 700 1_
- $a Marianowska, A
- 700 1_
- $a Wilkoswski, D
- 773 0_
- $w MED00004632 $t VASA $x 0301-1526 $g Roč. 33, č. 4 (2004), s. 219-225
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/15623197 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200911 $b ABA008
- 991 __
- $a 20200923101027 $b ABA008
- 999 __
- $a ok $b bmc $g 1563290 $s 1104002
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2004 $b 33 $c 4 $d 219-225 $e - $i 0301-1526 $m VASA $n VASA $x MED00004632
- LZP __
- $a Pubmed-20200911